TH174363B - Elements that are basic amino acids. For the regeneration of fibrelastin in the connective tissue of the skin. - Google Patents

Elements that are basic amino acids. For the regeneration of fibrelastin in the connective tissue of the skin.

Info

Publication number
TH174363B
TH174363B TH1701003013A TH1701003013A TH174363B TH 174363 B TH174363 B TH 174363B TH 1701003013 A TH1701003013 A TH 1701003013A TH 1701003013 A TH1701003013 A TH 1701003013A TH 174363 B TH174363 B TH 174363B
Authority
TH
Thailand
Prior art keywords
fibrelastin
regeneration
skin
elements
amino acids
Prior art date
Application number
TH1701003013A
Other languages
Thai (th)
Other versions
TH174363A (en
Original Assignee
โปรเฟชั่นแนล ไดเททิกส์ เอสพีเอ
Filing date
Publication date
Application filed by โปรเฟชั่นแนล ไดเททิกส์ เอสพีเอ filed Critical โปรเฟชั่นแนล ไดเททิกส์ เอสพีเอ
Publication of TH174363B publication Critical patent/TH174363B/en
Publication of TH174363A publication Critical patent/TH174363A/en

Links

Claims (1)

1. องค์ประกอบซึ่งมี, โดยเป็นส่วนผสมออกฤทธิ์, ของผสมของกรดอะมิโนซึ่งประกอบด้วย ไกซีน, L-โพรลีน, L-อะลานีน, L-วาลีน, L-ลิวซีน และ L-ไลซีน ไฮโดรคลอไรด์ ในอันตราส่วนโดย น้ำหนักดังต่อไปนี้ -ไกลซีน 1; -L-โพรลีน: 0.7-0.8; -L-อะลานีน: 0.47-0.76; -L-วาลีน: 0.35-0.56; -L-ลิวซีน: 0.13-0.27; -L-ไลซีน ไฮโดรคลอไรด์: 0.10-0.12:1. Composition which contains, as an active ingredient, amino acid mixture consisting of geysine, L-proline, L-alanine, L-valine, L-leucine and L- Lysine hydrochloride in the endangered parts by The following weights - glycine 1; -L-proline: 0.7-0.8; -L-alanine: 0.47-0.76; -L-Valine: 0.35-0.56; -L-Leucine: 0.13-0.27; -L-Lysine Hydrochloride: 0.10-0.12:
TH1701003013A 2015-12-03 Elements that are basic amino acids. For the regeneration of fibrelastin in the connective tissue of the skin. TH174363A (en)

Publications (2)

Publication Number Publication Date
TH174363B true TH174363B (en) 2018-03-15
TH174363A TH174363A (en) 2018-03-15

Family

ID=

Similar Documents

Publication Publication Date Title
IL281024A (en) Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
UA116004C2 (en) Pharmaceutical composition with improved bioavailability
BR112017009405A2 (en) antibiotic compositions.
WO2016118014A3 (en) Anti-senescence compounds and uses thereof
MX2021001169A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino}acetic acid, compositions, and uses thereof.
ECSP099685A (en) SULFUR COMPOUNDS AS INHIBITORS OF THE SERINA PROTEASA NS3 OF THE HEPATITIS C VIRUS
CO6551683A2 (en) TREATMENT FOR GASTROINTESTINAL DISORDERS
EA201890815A1 (en) AMINO ACID COMPOSITIONS WITH MODIFIED DELIVERY FOR ORAL ADMINISTRATION
EA200970532A1 (en) FUMARATE SALT (ALPHA S, BETA R) -6-BRUM-ALPHA- [2- (DIMETHYLAMINO) ETHYL] -2-METHOXY-ALPHA-1-NAPHTHALENYL-BETA-PHENYL-3-HINOLINETHANOL
EA201691171A1 (en) COMPOSITION APPLICABLE FOR ACTIVATION OF FEMALE REPRODUCTIVE ABILITY
WO2017062500A3 (en) Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies
WO2008093058A3 (en) Peptides and their use
BR112016028843A2 (en) solid forms of an antiviral compound
BR112014028130A2 (en) HYDROchloride salt of a peptide, pharmaceutical composition, use of a hydrochloride salt, use of a pharmaceutical composition, and method of preventing or treating cat allergy
CO2020006789A2 (en) Procedure for the preparation of (3s) -3- (4-chloro-3 - {[(2s, 3r) -2- (4-chlorophenyl) -4,4,4-trifluoro-3-methylbutanoyl] amino} phenyl) -3-cyclopropylpropanoic acid and its crystalline form for use as an active pharmaceutical ingredient
CA3010788A1 (en) Methods of administering vasopressors
MX2019006943A (en) Polypeptides for managing viral infections.
EA201591717A1 (en) Solid Forms of Vumurafenib Hydrochloride
BR112019003816A2 (en) hair rinse treatment composition, method for treating chemically damaged hair and use of a composition
MX2017010666A (en) (2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-met hyloxazole-2-carbonyl)amino]pentanoic acid.
UA113540C2 (en) N- (2-METHOXYBENZOYL) POLYMORPHS -4 - $ (METHYLAMINOCARBONYL) AMINO] BENZOLSULPHONAMIDE
AU2012280776B2 (en) Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
EA201691792A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON VILDAGLIPTINA
NZ630033A (en) Crystalline forms of 1-(3-tert-butyl-1-p-tolyl-1h-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-indazol-5-yloxy)benzyl)urea hydrochloride
JP2017517561A5 (en)